Project Details
Description
A Phase 3, multi-center, open-label extension study designed to describe the safety, tolerability, and efficacy of long-term administration of the human monoclonal
| Status | Finished |
|---|---|
| Effective start/end date | 12/6/07 → 12/31/12 |
Funding
- ABBOTT LABORATORIES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.